Literature DB >> 20814244

AKT-ing via microRNA.

Danish Sayed1, Maha Abdellatif.   

Abstract

MicroRNAs are involved in almost every aspect of a mammalian cell's functionality, from stem cell differentiation to aging and pathogenesis; however, their role in immediate cell signaling is less defined. This has been recently demonstrated by the rapid increase or decrease of miR-21's abundance within minutes of activation or inhibition of the AKT pathway, respectively, which mediates its regulation of Fas ligand (FasL) and phosphatase and tensin homologue deleted on chromosome 10 (PTEN) expression, among other targets. Conversely, AKT induces rapid downregulation of miR-199a-5p to effect upregulation of hypoxia-inducible factor 1α Hif-1α and sirtuin 1 (Sirt1). This suggests that posttranscriptional mechanisms regulate miRNAs' processing and/or stability to induce the rapid fluctuation in their levels. In support, a growing number of studies are showing specific posttranscriptional regulation of miRNAs. The data potentially explain how AKT, and plausibly other signaling pathways, can specifically and promptly modulate a gene's translation while circumventing the need for transcription during transient signaling events. In this article we present our views regarding cell signaling via miRNAs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814244      PMCID: PMC3041162          DOI: 10.4161/cc.9.16.12634

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation.

Authors:  Toshimitsu Suhara; Hyo-Soo Kim; Lorrie A Kirshenbaum; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis.

Authors:  R T Rowland; X Meng; J C Cleveland; D R Meldrum; A H Harken; J M Brown
Journal:  J Surg Res       Date:  1997-08       Impact factor: 2.192

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.

Authors:  S M Uriarte; S Joshi-Barve; Z Song; R Sahoo; L Gobejishvili; V R Jala; B Haribabu; C McClain; S Barve
Journal:  Cell Death Differ       Date:  2005-03       Impact factor: 15.828

5.  Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C.

Authors:  H Tong; W Chen; C Steenbergen; E Murphy
Journal:  Circ Res       Date:  2000-08-18       Impact factor: 17.367

6.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

7.  Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells.

Authors:  Iwona Ciechomska; Beata Pyrzynska; Piotr Kazmierczak; Bozena Kaminska
Journal:  Oncogene       Date:  2003-10-23       Impact factor: 9.867

8.  General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.

Authors:  G L Wang; G L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.

Authors:  Hong-Yan Ling; He-Sheng Ou; Shui-Dong Feng; Xiao-Ying Zhang; Qin-Hui Tuo; Lin-Xi Chen; Bing-Yang Zhu; Zhi-Ping Gao; Cao-Ke Tang; Wei-Dong Yin; Liang Zhang; Duan-Fang Liao
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-05-19       Impact factor: 2.557

Review 10.  The mechanism of action of the tumour suppressor gene PTEN.

Authors:  Alice Hlobilková; Jana Knillová; Jirí Bártek; Jirí Lukás; Zdenek Kolár
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2003-11       Impact factor: 1.245

View more
  27 in total

1.  PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis.

Authors:  P Briata; W-J Lin; M Giovarelli; M Pasero; C-F Chou; M Trabucchi; M G Rosenfeld; C-Y Chen; R Gherzi
Journal:  Cell Death Differ       Date:  2011-09-02       Impact factor: 15.828

2.  MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling.

Authors:  Vien Khach Lai; Muhammad Ashraf; Shujia Jiang; Khawaja Haider
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

3.  The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance.

Authors:  Oscar Tapia; Ismael Riquelme; Pamela Leal; Alejandra Sandoval; Susana Aedo; Helga Weber; Pablo Letelier; Enrique Bellolio; Miguel Villaseca; Patricia Garcia; Juan Carlos Roa
Journal:  Virchows Arch       Date:  2014-05-21       Impact factor: 4.064

4.  miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition.

Authors:  Huihui Guo; Xilin Zhang; Qiuqiang Chen; Ying Bao; Chaohui Dong; Xiang Wang
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

5.  Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.

Authors:  Linda S Steelman; Patrick Navolanic; William H Chappell; Stephen L Abrams; Ellis W T Wong; Alberto M Martelli; Lucio Cocco; Franca Stivala; Massimo Libra; Ferdinando Nicoletti; Lyudmyla B Drobot; Richard A Franklin; James A McCubrey
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

Review 6.  MicroRNAs and their roles in aging.

Authors:  Thalyana Smith-Vikos; Frank J Slack
Journal:  J Cell Sci       Date:  2012-01-01       Impact factor: 5.285

7.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

Review 8.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression.

Authors:  Brian Keith; Randall S Johnson; M Celeste Simon
Journal:  Nat Rev Cancer       Date:  2011-12-15       Impact factor: 60.716

Review 9.  Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a.

Authors:  Shen Gu; Wai-Yee Chan
Journal:  Int J Mol Sci       Date:  2012-07-09       Impact factor: 6.208

Review 10.  Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity.

Authors:  Luqing Zhao; Ann M Bode; Ya Cao; Zigang Dong
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.